“硬科技”企业成长路径更清晰——科创板科创成长层迎来首批新注册企业上市
Jing Ji Ri Bao·2025-11-04 22:08

Core Insights - The launch of the first three new registered companies in the Sci-Tech Innovation Board's growth layer marks a significant enhancement in the capital market's inclusivity and adaptability [1][2][3] - The Sci-Tech Innovation Board has gathered 592 technology companies with a total market capitalization exceeding 9 trillion yuan, establishing itself as the preferred listing venue for "hard tech" companies in China [1][4] - A series of policy measures, including the "New National Nine Articles" and the "1+6" policies, have aligned the growth paths of "hard tech" companies with the support cycles of the capital market, injecting new vitality into the support for technological innovation [1][2][5] Policy and Market Developments - The China Securities Regulatory Commission (CSRC) introduced the "1+6" policy on June 18, 2023, which includes the establishment of a growth layer on the Sci-Tech Innovation Board aimed at supporting technology companies that are not yet profitable but have significant breakthroughs and commercial prospects [2][3] - The three newly listed companies—He Yuan Bio, Xi'an Yicai, and Bibet—are the first to be registered under this growth layer, optimizing listing standards and enhancing financing channels for high-investment sectors like artificial intelligence and innovative pharmaceuticals [2][3][4] - Since the establishment of the Sci-Tech Innovation Board in November 2018, it has supported the listing of 592 companies in high-tech and strategic emerging industries, raising over 1.1 trillion yuan through IPOs and refinancing [4][5] Financial Performance and R&D Investment - In 2024, the total R&D investment of companies on the Sci-Tech Innovation Board is projected to reach 168.1 billion yuan, which is more than three times the net profit of the board, reflecting a year-on-year growth of 6.4% [5] - By the first half of 2025, R&D investment is expected to reach 84.1 billion yuan, exceeding net profit by 2.8 times, with a median R&D investment as a percentage of revenue at 12.6% [5] Future Directions and Regulatory Enhancements - The Shanghai Stock Exchange plans to enhance its role as a "testbed" for reforms, focusing on identifying high-quality technology companies and supporting sectors like artificial intelligence and commercial aerospace [7] - The CSRC emphasizes the need for continuous improvement in the capital market's inclusivity and adaptability, aiming to deepen reforms in areas such as issuance, underwriting, and mergers and acquisitions [6][7] - There is a strong focus on investor protection and the development of patient and long-term capital to improve market attractiveness and competitiveness [7]